TABLE 6.
Comparison of adverse drug reactions between the two groups at 6-month follow-up.
| Group | Adverse drug reactions, n (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Liver enzyme elevation | Rash | Dry cough | Local bleeding | Headache | Abdominal distention | Gastrointestinal bleeding | Insomnia | Total | |
| CPC group | 2 (1.77) | 1 (0.88) | 1 (0.88) | 1 (0.88) | 0 (0) | 1 (0.88) | 0 (0) | 0 (0) | 6 (5.31) |
| UC group | 8 (6.96) | 0 (0) | 0 (0) | 0 (0) | 3 (2.61) | 2 (1.74) | 1 (0.87) | 1 (0.87) | 15 (13.04) |
| χ 2 | — | — | — | — | — | — | — | — | 4.077 |
| p-value | — | — | — | — | — | — | — | — | 0.043 a |
a
Pearson Chi-square test.
The italic values mean statistically significant. A p-value <0.05 was considered statistically significant.